Report: PBM Gross Profits Rose 12% From 2017-2019

leozini
Dec 6, 2021
1 min read

Pharmaceutical middlemen saw gross profits increase by 12% from 2017 to 2019, according to a report by the PBM Accountability Project . The report said the source of profits varied substantially and included common tactics such as spread pricing and retroactive claw back fees...

Read full story >

PBM Accountability Project Statement on Administration’s April 15 Executive Order

The White House issued an executive order (EO) on April 15 aimed at “Lowering Drug Prices by Once Again Putting Americans First.” The...

PBM Accountability Project Statement on Critical PBM Reforms in Congress

Many Congressional leaders and stakeholders continue to highlight the need for the PBM reforms. Representative Buddy Carter (R-GA)...

PBM Accountability Project Statement on House Introduction of Critical PBM Reforms

Representatives Mariannette Miller-Meeks, M.D. (R-IA), Nannette Barragan (D-CA), Nicole Malliotakis (R-NY), Brad Schneider (D-IL), Rick...